doppler showed a patent foramen ovale with bidirectional shunting, not evident in review of the pretherapy echocardiogram. During a valsalva maneuver, the flow across the We describe a patient who developed a paradoxical embolus to the brain during infusion of bone marrow.
Case 1
Discussion A 10-year-old female had monosomy-7, that progressed to acute myelogenous leukemia. The pretreatment echocardioWe describe two patients with potential for right-to-left cargram was normal. After conditioning, the patient was prediac shunting during bone marrow infusion: one with an medicated with hydrocortisone, diphenhydramine and acetunrecognized patent foramen ovale, and the other with an aminophen and received 300 ml of bone marrow, atrial septal defect. The patent foramen ovale was not intravenously through a double lumen catheter, placed at detected by a normal screening echocardiogram. Our the junction of the superior vena cava and the right atrium. hypothesis is that during marrow infusion (with the During the infusion she vomited and developed a severe accompanying increase in the central venous pressure and occipital headache, which persisted after the infusion was right atrial pressure), possibly accentuated by vomiting, completed. Blood pressure was normal. A CT scan perforthere was right-to-left shunting, allowing particles to med that day was unremarkable. In the hours after the marembolize to the brain. Post-transplant contrast transrow infusion, her headache worsened and the patient thoracic echocardiography showed shunting across the patdeveloped bilateral blindness, respiratory arrest and seizent foramen ovale during valsalva. ures. Angiography revealed multiple infarcts consistent
The incidence of patent foramen ovale is reported to with emboli. A repeat 2-D echocardiogram with color be 10-34%.
1-4
The ability of routine trans-thoracic echocardiography to detect a patent foramen ovale is low. Detection may be improved by the use of trans-esophageal morbidity and discomfort for patients as well as increase References the overall cost of pretransplant work-up for BMT. Very few patients with patent foramen ovale who are trans- Circulation 1992; 86: 1902 -1908 the catheter at the completion of the infusion.
